Melanoma gene expression and clinical course

Archives of Dermatological Research

Volumn 301, Issue 9, 2009, Pages 673-679

  Vourc'H Jourdain, M ^a   Volteau, C ^c   Nguyen, J M ^c   Khammari, A ^b   Dreno, Brigitte ^a,b  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b Team 12   (France)

^c PIMESP Pole d'Information Médicale et d'Evaluation en Santé Publique   (France)

Author keywords

Melanoma; Melanoma antigen encoding genes; Prognosis; Survival

Indexed keywords

MELAN A; MELANOMA ANTIGEN; MELANOMA ANTIGEN 1; MELANOMA ANTIGEN 3; MONOPHENOL MONOOXYGENASE; NA 17A PROTEIN; NY ESO 1 ANTIGEN; TUMOR PROTEIN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CHILD; DISEASE COURSE; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; INFANT; LYMPH NODE; MALE; MELANOMA; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SKIN BIOPSY; TUMOR GENE; VISCERA;

AGED; ANTIGENS, NEOPLASM; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LYMPHATIC METASTASIS; MALE; MELANOMA; MEMBRANE PROTEINS; NEOPLASM PROTEINS; NEOPLASM STAGING; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 69549089948     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-009-0944-8     Document Type: Article

References (19)

1. CM Balch AC Buzaid SJ Soong, et al. 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 3648
2. C Barrow J Browning D Macgregor, et al. 2006 Tumor antigen expression in melanoma varies according to antigen and stage Clin Cancer Res 12 673 678 10.1158/1078-0432.CCR-05-1544 (Pubitemid 43259856)
3. JL Bulliard 2000 Site-specific risk of cutaneous malignant melanoma and pattern of sun exposure in New Zealand Int J Cancer 85 627 632
4. JJ De Vries M Smeets R de Graaf, et al. 2001 Expression of gp100, MART-1, tyrosinase, and S100 in paraffin-embedded primary melanomas and locoregional, lymph node, and visceral metastases: implications for diagnosis and immunotherapy. A study conducted by the EORTC Melanoma Cooperative Group J Pathol 193 1 13 20
5. CD Enk M Lotem Z Gimon 2004 Molecular detection of MART1, tyrosinase and MIA in peripheral blood, lymph nodes and metastatic sites of stage III/IV melanoma patients Melanoma Res 14 5 361 365
6. B Farthmann 1998 RT-PCR tyrosinase-mRNA-positive cells in peripheral blood: evaluation strategy and correlation with known prognostic markers in 123 melanoma patients J Invest Dermatol 110 3 263 267
7. EC Hsueh L Nathanson LJ Foshag, et al. 1999 Active specific immunotherapy with polyvalent melanoma cell vaccine for patients with in-transit melanoma metastases Cancer 85 2160 2169
8. E Jäger M Ringhoffer M Altmannsberger, et al. 1997 Immunoselection in vivo: independent loss of CMH class I and melanocyte differentiation antigen expression in metastatic melanoma Int J Cancer 71 142 147
9. E Jäger M Ringhoffer HP Dienes, et al. 1996 Granulocyte-macrophage- colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo Int J Cancer 67 54 62
10. DL Morton A Barth 1996 Vaccine therapy for malignant melanoma CA Cancer J Clin 46 225 244
11. D Morton LJ Foshag DS Hoon, et al. 1992 Prolongation of survival in metastatic melanoma after active specific immunotherapy with a new polyvalent melanoma vaccine Ann Surg 216 463 482
12. AV Parisi MG Kimlin R Lester D Turnbull 2003 Lower body anatomical distribution of solar ultraviolet radiation on the human form in standing and sitting postures J Photochem Photobiol B 69 1 6
13. G Parmiani C Castelli P Dalerba, et al. 2002 Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going? J Natl Cancer Inst (Bethesda) 94 805 818
14. DS Rigel 2008 Cutaneous ultraviolet exposure and its relationship to the development of skin cancer J Am Acad Dermatol 58 S2 S129 S132
15. T Sarantou DD Chi DA Garrison, et al. 1997 Melanoma associated antigens as messenger RNA detection markers for melanoma Cancer Res 57 1371 1376
16. C Scheibenbogen D Nagorsen B Seliger, et al. 2002 Long term freedom from recurrence in 2 stage melanoma patients following vaccination with tyrosinase peptides Int J Cancer 99 403 408
17. H Takeuchi C Kuo DL Morton, et al. 2003 Expression of differentiation Melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas Cancer Res 63 441 448
18. U Trefzer M Hofmann S Reinke 2006 Concordant loss of melanoma differentiation antigens in synchronous and asynchronous melanoma metastases: implications for immunotherapy Melanoma Res 16 2 137 145
19. EF Velasquez AA Jungblut M Yancovitz, et al. 2007 Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors Cancer Immun 12 7 11